Continuous dopaminergic stimulation achieved by duodenal levodopa infusion

Per Odin, Erik Wolters, Angelo Antonini

Research output: Contribution to journalArticle

Abstract

Continuous dopaminergic stimulation is the ideal approach for the management of Parkinson's disease (PD); this goal can be partially reached with dopamine agonists, but the need for a therapeutic strategy providing a strong and constant dopaminergic stimulation also in the advanced phase of the disease remains unmet. The application of levodopa/ carbidopa-gel suspension directly in the duodenum (Duodopa) allows a continuous delivery by a portable pump, resulting in smoother levodopa plasmatic concentrations, and consequently in a physiologic continuous receptor stimulation. Clinical studies have demonstrated that duodenal infusion was associated with significantly better outcome compared to conventional treatment regarding global functioning, ability to walk, "off" time and motor fluctuations. A retrospective analysis of the long-term clinical experience with Duodopa evidenced that daily dose of levodopa decreased by 5% during follow-up. The profile of pharmacological adverse events of Duodopa was similar to that observed with oral administration; dislocation of the intestinal tube to the stomach was the most common technical problem.

Original languageEnglish
JournalNeurological Sciences
Volume29
Issue numberSUPPL. 5
DOIs
Publication statusPublished - 2008

Keywords

  • Continuous dopaminergic stimulation
  • Dopamine agonists
  • Duodenal levodopa infusion

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology

Fingerprint Dive into the research topics of 'Continuous dopaminergic stimulation achieved by duodenal levodopa infusion'. Together they form a unique fingerprint.

  • Cite this